MedPath

Vidanga arka in fungal infection of ear

Phase 2/3
Completed
Conditions
Other specified disorders of external ear. Ayurveda Condition: KARNASULAH,
Registration Number
CTRI/2022/09/045405
Lead Sponsor
Dr Savitri B Saunshimath
Brief Summary

In this comparative clinical study, *Vidanga Arka* is taken as the trial drug and *Madhu* is taken as the control drug. *Arka* preparations are not only potent, they are also sterile, and have a longer shelf life. The mode of administration of drugs as ear dropsis simple and cost effective in the management of Otomycosis**.** Therefore, in this present study, an effort has been made to evaluate and compare the efficacies of *Vidanga Arka* and *Madhu* in the management of *Karnashoola* w.s.r.toOtomycosis*.*

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Subjects fulfilling the diagnostic criteria.
  • Subjects within the age of 21 to 60 years irrespective of gender, occupation, religion, socio- economic status and duration of illness.
  • Subjects willing to sign the informed consent.
Exclusion Criteria
  • Subjects having perforated tympanic membrane.
  • Subjects with other aural pathologies (external, middle and inner ear pathologies).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
changes in the following symptoms will be documented1.0th day - Before treatment | 2.7th day - After treatment | 3.14th day - Follow up 1 | 4.21st day - Follow up 2 | 5.28th day – Follow up 3
1. karnashoola1.0th day - Before treatment | 2.7th day - After treatment | 3.14th day - Follow up 1 | 4.21st day - Follow up 2 | 5.28th day – Follow up 3
2. karnakandu1.0th day - Before treatment | 2.7th day - After treatment | 3.14th day - Follow up 1 | 4.21st day - Follow up 2 | 5.28th day – Follow up 3
3. karnasrava1.0th day - Before treatment | 2.7th day - After treatment | 3.14th day - Follow up 1 | 4.21st day - Follow up 2 | 5.28th day – Follow up 3
4. karnapratinaha1.0th day - Before treatment | 2.7th day - After treatment | 3.14th day - Follow up 1 | 4.21st day - Follow up 2 | 5.28th day – Follow up 3
Secondary Outcome Measures
NameTimeMethod
fungal mass will be assessed using aural endoscopy1.0th day - Before treatment

Trial Locations

Locations (1)

SRI SRI COLLEGE OF AYURVEDA SCIENCE AND RESEARCH HOSPITAL

🇮🇳

Bangalore, KARNATAKA, India

SRI SRI COLLEGE OF AYURVEDA SCIENCE AND RESEARCH HOSPITAL
🇮🇳Bangalore, KARNATAKA, India
DR SAVITRI B SAUNSHIMATH
Principal investigator
07204460302
savitrisaunshimath9@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.